Moneycontrol PRO
UPCOMING EVENT:Are you 45+? Planning for retirement? We have just the right webinar for you - Planning for Retirement with Life Insurance on 27-Jan, 3pm. Register now!
you are here: HomeNewsBusiness

Serum Institute says India trials of COVID-19 vaccine ongoing

AstraZeneca said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.

September 09, 2020 / 09:47 PM IST

Serum Institute of India said on Wednesday that trials of AstraZeneca Plc's COVID-19 vaccine candidate in the country is ongoing and has not faced any issues.

AstraZeneca said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.

"We can't comment much on the U.K. trials," Serum Institute said in a statement, adding "as far as Indian trials are concerned, it is continuing and we have faced no issues at all."
Reuters
Sections
ISO 27001 - BSI Assurance Mark